These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35586807)

  • 1. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-
    Jin F; Zhang L; Chen K; Miao Y; Liu Y; Tian Y; Li J
    Biomed Res Int; 2022; 2022():3360771. PubMed ID: 35586807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
    Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D
    J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway.
    Li MY; Qin YQ; Tian YG; Li KC; Oliver BG; Liu XF; Zhao P; Li JS
    BMC Pulm Med; 2022 Nov; 22(1):434. PubMed ID: 36414945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling.
    Xu K; Ma J; Lu R; Shao X; Zhao Y; Cui L; Qiu Z; Tian Y; Li J
    Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 36799253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-
    Ma J; Tian Y; Li J; Zhang L; Wu M; Zhu L; Liu S
    Evid Based Complement Alternat Med; 2019; 2019():6708645. PubMed ID: 31275415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway.
    Liu Y; Zhang L; Zhao J; Lu R; Shao X; Xu K; Li J; Tian Y
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1905-1920. PubMed ID: 39206144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of electroacupuncture on SIRT1/NF-κB signaling pathway in adipose tissue of obese rats].
    Huang Q; Chen R; Peng M; Li L; Li T; Liang FX; Xu F
    Zhongguo Zhen Jiu; 2020 Feb; 40(2):185-91. PubMed ID: 32100506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compatibility characteristics of Bufei Yishen formula III in regulating chronic obstructive pulmonary disease mucus hypersecretion].
    Qin Y; Li M; Tian Y; Zhao P; Li K; Li C; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1309-1314. PubMed ID: 34980299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease.
    Li Y; Li JS; Li WW; Li SY; Tian YG; Lu XF; Jiang SL; Wang Y
    BMC Complement Altern Med; 2014 Apr; 14():140. PubMed ID: 24766819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of electroacupuncture combined with Zhuang-medicine-thread moxibustion on silent information regulator-1/nuclear factor κB signaling pathway in gastric antrum of diabetic gastroparesis rats].
    Mai W; Fan YS; Miao FR; He C; Huang LL; Zhao XJ; Nie YJ; Pang RK
    Zhen Ci Yan Jiu; 2021 Oct; 46(10):837-44. PubMed ID: 34698457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway.
    Ma J; Liu X; Wei Y; Lu R; Xu K; Tian Y; Li J
    Evid Based Complement Alternat Med; 2022; 2022():9423435. PubMed ID: 36619199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease.
    Huang L; Guan Q; Lu R; Zhang Z; Liu C; Tian Y; Li J
    Ann Med; 2024 Dec; 56(1):2403729. PubMed ID: 39276358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38.
    Li J; Xie Y; Zhao P; Qin Y; Oliver BG; Tian Y; Li S; Wang M; Liu X
    Phytomedicine; 2021 Mar; 83():153475. PubMed ID: 33545548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electro-acupuncture regulates the cholinergic anti-inflammatory pathway in a rat model of chronic obstructive pulmonary disease.
    Zhang XF; Xiang SY; Geng WY; Cong WJ; Lu J; Jiang CW; Wang K; Liu ZB
    J Integr Med; 2018 Nov; 16(6):418-426. PubMed ID: 30341024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective-component compatibility of Bufei Yishen formula alleviates chronic obstructive pulmonary disease inflammation by regulating GSK3β-mediated NLRP3 inflammasome activation.
    Qin Y; Zhai J; Yang J; Li H; Tian Y; Liu X; Zhao P; Li J
    Biomed Pharmacother; 2023 Dec; 168():115614. PubMed ID: 37862971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease.
    Li JS; Liu XF; Dong HR; Zheng WC; Feng SX; Tian YG; Zhao P; Ma JD; Ren ZX; Xie Y
    J Integr Med; 2020 Jul; 18(4):351-362. PubMed ID: 32565294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of electroacupuncture on miR-34a-5p/SIRT1 signaling in the trigeminal ganglion of rats with migraine].
    Zhang H; He SD; Zong DD; Zhang XM; Luo J; Zheng JK
    Zhen Ci Yan Jiu; 2020 Nov; 45(11):868-74. PubMed ID: 33269829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroacupuncture regulates microglial polarization via inhibiting NF-κB/COX2 pathway following traumatic brain injury.
    Zhang XH; Cui H; Zheng SM; Lu Y; Yuan HW; Zhang L; Wang HH; Du RS
    Brain Res; 2023 Nov; 1818():148516. PubMed ID: 37562566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155/FOXO3a pathway.
    Li J; Wang J; Li Y; Zhao P; Tian Y; Liu X; He H; Jia R
    Ecotoxicol Environ Saf; 2021 Nov; 228():112918. PubMed ID: 34773846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective-components combination alleviates PM2.5-induced inflammation by evoking macrophage autophagy in COPD.
    Wang J; He W; Yue H; Zhao P; Li J
    J Ethnopharmacol; 2024 Mar; 321():117537. PubMed ID: 38043756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.